141 related articles for article (PubMed ID: 32189325)
21. Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.
Maurino J; Martínez-Ginés ML; García-Domínguez JM; Solar MD; Carcelén-Gadea M; Ares-Luque A; Ballabriga J; Navarro-Cantó L; Medrano N; Honan CA;
Mult Scler Relat Disord; 2020 Jun; 41():102046. PubMed ID: 32179482
[TBL] [Abstract][Full Text] [Related]
22. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis.
Dulau C; Deloire M; Diaz H; Saubusse A; Charre-Morin J; Prouteau A; Brochet B
J Neurol; 2017 Apr; 264(4):740-748. PubMed ID: 28220288
[TBL] [Abstract][Full Text] [Related]
23. Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.
He A; Manouchehrinia A; Glaser A; Ciccarelli O; Butzkueven H; Hillert J; McKay KA
JAMA Netw Open; 2023 Sep; 6(9):e2334675. PubMed ID: 37751208
[TBL] [Abstract][Full Text] [Related]
24. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
25. Body Esteem Among Women with Multiple Sclerosis and its Relationship with Demographic, Clinical and Socio-Psychological Factors.
Wilski M; Tasiemski T; Dąbrowski A
Int J Behav Med; 2016 Jun; 23(3):340-347. PubMed ID: 26667934
[TBL] [Abstract][Full Text] [Related]
26. [Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].
Jamroz-Wiśniewska A; Papuć E; Bartosik-Psujek H; Belniak E; Mitosek-Szewczyk K; Stelmasiak Z
Neurol Neurochir Pol; 2007; 41(3):215-22. PubMed ID: 17629814
[TBL] [Abstract][Full Text] [Related]
27. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.
Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
Mult Scler; 2003 Aug; 9(4):411-9. PubMed ID: 12926848
[TBL] [Abstract][Full Text] [Related]
28. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
[TBL] [Abstract][Full Text] [Related]
29. Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.
Regnault A; Loubert A; Brennan R; Meunier J; Naujoks C; Cano S; Adlard N
Mult Scler J Exp Transl Clin; 2023; 9(3):20552173231201422. PubMed ID: 37780483
[TBL] [Abstract][Full Text] [Related]
30. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
Ayatollahi P; Nafissi S; Eshraghian MR; Kaviani H; Tarazi A
Mult Scler; 2007 Mar; 13(2):275-7. PubMed ID: 17439899
[TBL] [Abstract][Full Text] [Related]
31. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
Goodwin E; Green C; Hawton A
Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
[TBL] [Abstract][Full Text] [Related]
32. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
[TBL] [Abstract][Full Text] [Related]
33. Comparison of patient-reported outcome measures in multiple sclerosis.
Schäffler N; Schönberg P; Stephan J; Stellmann JP; Gold SM; Heesen C
Acta Neurol Scand; 2013 Aug; 128(2):114-21. PubMed ID: 23398571
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
Wilski M; Tasiemski T
Qual Life Res; 2016 Jul; 25(7):1761-70. PubMed ID: 26676150
[TBL] [Abstract][Full Text] [Related]
35. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical).
Costelloe L; O'Rourke K; Kearney H; McGuigan C; Gribbin L; Duggan M; Daly L; Tubridy N; Hutchinson M
J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):841-4. PubMed ID: 17332049
[TBL] [Abstract][Full Text] [Related]
36. Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study.
Giordano A; Pucci E; Naldi P; Mendozzi L; Milanese C; Tronci F; Leone M; Mascoli N; La Mantia L; Giuliani G; Solari A
J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):1023-8. PubMed ID: 19443471
[TBL] [Abstract][Full Text] [Related]
37. Self-assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow-up.
Giordano A; Ferrari G; Radice D; Randi G; Bisanti L; Solari A;
Eur J Neurol; 2013 Apr; 20(4):681-8. PubMed ID: 23217086
[TBL] [Abstract][Full Text] [Related]
38. Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
Al-Asmi A; Al-Rawahi S; Al-Moqbali ZS; Al-Farsi Y; Essa MM; El-Bouri M; Koshy RP; Gujjar AR; Jacob PC; Al-Hodar A; Al Adawi S
BMC Neurol; 2015 Aug; 15():131. PubMed ID: 26242758
[TBL] [Abstract][Full Text] [Related]
39. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales.
Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1539-43. PubMed ID: 16227547
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing-remitting multiple sclerosis using classical and modern test theory.
Bacci ED; Wyrwich KW; Phillips GA; Vollmer T; Guo S
Mult Scler J Exp Transl Clin; 2016; 2():2055217316673235. PubMed ID: 28607741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
